Dynavax Technologies Corporation (DVAX) stock news · rev $277.2M
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This DVAX news page leads with what Dynavax Technologies Corporation filed — not a scraped headline mill.
No cached 8-K sentence for DVAX yet. We will not pad this page with generic market recap.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the DVAX stock page; for the tape open the quote page.
DVAX stock news FAQ
What are DVAX's latest revenue and net income?
Latest cached Dynavax Technologies Corporation (DVAX) revenue for Dec 31, 2024 was $277.2M. Net income was $27.3M. Statements: https://lician.com/financials/dvax
How did DVAX revenue change from the prior cached period?
Cached Dynavax Technologies Corporation (DVAX) revenue was up 19.4% from $232.3M (Dec 31, 2023) to $277.2M (Dec 31, 2024). Statements: https://lician.com/financials/dvax
What is DVAX's market cap?
Dynavax Technologies Corporation (DVAX) market cap is $1.82B on the latest cached fundamentals snapshot.
What kind of company is DVAX?
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is DVAX stock news listed?
Cached stock news for Dynavax Technologies Corporation (DVAX) is listed at https://lician.com/news/dvax. Filings: https://lician.com/sec/dvax
Not investment advice.